Service Corporation International
Get $10 bonus on your first $100 deposit for SCI
Get $10 bonus on your first $100 deposit for SCI
Service Corporation International (SCI) Stock Competitors & Peer Comparison
See (SCI) competitors and their performances in Stock Market.
Peer Comparison Table: Personal Products & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SCI | $85.85 | +2.56% | 11.8B | 22.27 | $3.80 | +0.81% |
| ROL | $55.87 | +2.12% | 26.7B | 50.76 | $1.09 | +0.67% |
| BFAM | $82.76 | -2.94% | 4.7B | 25.30 | $3.36 | N/A |
| FTDR | $61.08 | -0.99% | 4.3B | 17.70 | $3.42 | N/A |
| CVSA | $109.13 | -7.33% | 4.1B | 17.35 | $6.79 | N/A |
| HRB | $31.18 | -3.47% | 4B | 7.36 | $4.28 | +2.60% |
| DSEY | $8.40 | +0.06% | 2.7B | -14.47 | -$0.58 | N/A |
| MCW | $6.99 | -0.09% | 2.3B | 22.55 | $0.31 | N/A |
| ROVR | $11.00 | +0.05% | 2B | 183.25 | $0.06 | N/A |
| CSV | $50.55 | +4.50% | 764.4M | 14.83 | $3.25 | +0.47% |
Stock Comparison
SCI vs ROL Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, ROL has a market cap of 26.7B. Regarding current trading prices, SCI is priced at $85.85, while ROL trades at $55.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas ROL's P/E ratio is 50.76. In terms of profitability, SCI's ROE is +0.34%, compared to ROL's ROE of +0.37%. Regarding short-term risk, SCI is less volatile compared to ROL. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check ROL's competition here
SCI vs BFAM Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, BFAM has a market cap of 4.7B. Regarding current trading prices, SCI is priced at $85.85, while BFAM trades at $82.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas BFAM's P/E ratio is 25.30. In terms of profitability, SCI's ROE is +0.34%, compared to BFAM's ROE of +0.14%. Regarding short-term risk, SCI is less volatile compared to BFAM. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check BFAM's competition here
SCI vs FTDR Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, FTDR has a market cap of 4.3B. Regarding current trading prices, SCI is priced at $85.85, while FTDR trades at $61.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas FTDR's P/E ratio is 17.70. In terms of profitability, SCI's ROE is +0.34%, compared to FTDR's ROE of +1.01%. Regarding short-term risk, SCI is less volatile compared to FTDR. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check FTDR's competition here
SCI vs CVSA Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, CVSA has a market cap of 4.1B. Regarding current trading prices, SCI is priced at $85.85, while CVSA trades at $109.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas CVSA's P/E ratio is 17.35. In terms of profitability, SCI's ROE is +0.34%, compared to CVSA's ROE of +0.18%. Regarding short-term risk, SCI is less volatile compared to CVSA. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check CVSA's competition here
SCI vs HRB Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, HRB has a market cap of 4B. Regarding current trading prices, SCI is priced at $85.85, while HRB trades at $31.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas HRB's P/E ratio is 7.36. In terms of profitability, SCI's ROE is +0.34%, compared to HRB's ROE of -1.66%. Regarding short-term risk, SCI is less volatile compared to HRB. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check HRB's competition here
SCI vs DSEY Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, DSEY has a market cap of 2.7B. Regarding current trading prices, SCI is priced at $85.85, while DSEY trades at $8.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas DSEY's P/E ratio is -14.47. In terms of profitability, SCI's ROE is +0.34%, compared to DSEY's ROE of -0.23%. Regarding short-term risk, SCI is more volatile compared to DSEY. This indicates potentially higher risk in terms of short-term price fluctuations for SCI.Check DSEY's competition here
SCI vs MCW Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, MCW has a market cap of 2.3B. Regarding current trading prices, SCI is priced at $85.85, while MCW trades at $6.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas MCW's P/E ratio is 22.55. In terms of profitability, SCI's ROE is +0.34%, compared to MCW's ROE of +0.09%. Regarding short-term risk, SCI is more volatile compared to MCW. This indicates potentially higher risk in terms of short-term price fluctuations for SCI.Check MCW's competition here
SCI vs ROVR Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, ROVR has a market cap of 2B. Regarding current trading prices, SCI is priced at $85.85, while ROVR trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas ROVR's P/E ratio is 183.25. In terms of profitability, SCI's ROE is +0.34%, compared to ROVR's ROE of -0.07%. Regarding short-term risk, SCI is more volatile compared to ROVR. This indicates potentially higher risk in terms of short-term price fluctuations for SCI.Check ROVR's competition here
SCI vs CSV Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, CSV has a market cap of 764.4M. Regarding current trading prices, SCI is priced at $85.85, while CSV trades at $50.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas CSV's P/E ratio is 14.83. In terms of profitability, SCI's ROE is +0.34%, compared to CSV's ROE of +0.22%. Regarding short-term risk, SCI is less volatile compared to CSV. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check CSV's competition here
SCI vs EM Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, EM has a market cap of 147.7M. Regarding current trading prices, SCI is priced at $85.85, while EM trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas EM's P/E ratio is -116.50. In terms of profitability, SCI's ROE is +0.34%, compared to EM's ROE of -0.01%. Regarding short-term risk, SCI is more volatile compared to EM. This indicates potentially higher risk in terms of short-term price fluctuations for SCI.Check EM's competition here
SCI vs MED Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, MED has a market cap of 120.9M. Regarding current trading prices, SCI is priced at $85.85, while MED trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas MED's P/E ratio is -6.44. In terms of profitability, SCI's ROE is +0.34%, compared to MED's ROE of -0.09%. Regarding short-term risk, SCI is more volatile compared to MED. This indicates potentially higher risk in terms of short-term price fluctuations for SCI.Check MED's competition here
SCI vs WW Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, WW has a market cap of 100M. Regarding current trading prices, SCI is priced at $85.85, while WW trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas WW's P/E ratio is 1.32. In terms of profitability, SCI's ROE is +0.34%, compared to WW's ROE of -26.25%. Regarding short-term risk, SCI is less volatile compared to WW. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check WW's competition here
SCI vs RGS Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, RGS has a market cap of 68.8M. Regarding current trading prices, SCI is priced at $85.85, while RGS trades at $27.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas RGS's P/E ratio is 0.61. In terms of profitability, SCI's ROE is +0.34%, compared to RGS's ROE of +0.71%. Regarding short-term risk, SCI is less volatile compared to RGS. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check RGS's competition here
SCI vs XSPA Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, XSPA has a market cap of 54.5M. Regarding current trading prices, SCI is priced at $85.85, while XSPA trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas XSPA's P/E ratio is 21.83. In terms of profitability, SCI's ROE is +0.34%, compared to XSPA's ROE of +35.63%. Regarding short-term risk, SCI is less volatile compared to XSPA. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check XSPA's competition here
SCI vs XWEL Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, XWEL has a market cap of 6.8M. Regarding current trading prices, SCI is priced at $85.85, while XWEL trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas XWEL's P/E ratio is -0.24. In terms of profitability, SCI's ROE is +0.34%, compared to XWEL's ROE of +1.77%. Regarding short-term risk, SCI is less volatile compared to XWEL. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check XWEL's competition here
SCI vs MRM Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, MRM has a market cap of 6.3M. Regarding current trading prices, SCI is priced at $85.85, while MRM trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas MRM's P/E ratio is 3.26. In terms of profitability, SCI's ROE is +0.34%, compared to MRM's ROE of +1.55%. Regarding short-term risk, SCI is less volatile compared to MRM. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check MRM's competition here
SCI vs EJH Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, EJH has a market cap of 5.4M. Regarding current trading prices, SCI is priced at $85.85, while EJH trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas EJH's P/E ratio is -0.03. In terms of profitability, SCI's ROE is +0.34%, compared to EJH's ROE of +0.01%. Regarding short-term risk, SCI is less volatile compared to EJH. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check EJH's competition here
SCI vs BYAH Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, BYAH has a market cap of 745.2K. Regarding current trading prices, SCI is priced at $85.85, while BYAH trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas BYAH's P/E ratio is N/A. In terms of profitability, SCI's ROE is +0.34%, compared to BYAH's ROE of -5.91%. Regarding short-term risk, SCI is less volatile compared to BYAH. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check BYAH's competition here
SCI vs TRNR Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, TRNR has a market cap of 153.5K. Regarding current trading prices, SCI is priced at $85.85, while TRNR trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas TRNR's P/E ratio is -0.01. In terms of profitability, SCI's ROE is +0.34%, compared to TRNR's ROE of -1.78%. Regarding short-term risk, SCI is less volatile compared to TRNR. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check TRNR's competition here
SCI vs IVP Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, IVP has a market cap of 85.8K. Regarding current trading prices, SCI is priced at $85.85, while IVP trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas IVP's P/E ratio is -0.00. In terms of profitability, SCI's ROE is +0.34%, compared to IVP's ROE of -5.20%. Regarding short-term risk, SCI is more volatile compared to IVP. This indicates potentially higher risk in terms of short-term price fluctuations for SCI.Check IVP's competition here
SCI vs YYGH Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, YYGH has a market cap of 25.4K. Regarding current trading prices, SCI is priced at $85.85, while YYGH trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas YYGH's P/E ratio is N/A. In terms of profitability, SCI's ROE is +0.34%, compared to YYGH's ROE of -1.00%. Regarding short-term risk, SCI is less volatile compared to YYGH. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check YYGH's competition here
SCI vs TMX Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, TMX has a market cap of 0. Regarding current trading prices, SCI is priced at $85.85, while TMX trades at $37.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas TMX's P/E ratio is 70.13. In terms of profitability, SCI's ROE is +0.34%, compared to TMX's ROE of +0.05%. Regarding short-term risk, SCI is less volatile compared to TMX. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check TMX's competition here
SCI vs NEBCU Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, NEBCU has a market cap of 0. Regarding current trading prices, SCI is priced at $85.85, while NEBCU trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas NEBCU's P/E ratio is N/A. In terms of profitability, SCI's ROE is +0.34%, compared to NEBCU's ROE of -0.00%. Regarding short-term risk, SCI is less volatile compared to NEBCU. This indicates potentially lower risk in terms of short-term price fluctuations for SCI.Check NEBCU's competition here
SCI vs STON Comparison April 2026
SCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCI stands at 11.8B. In comparison, STON has a market cap of 0. Regarding current trading prices, SCI is priced at $85.85, while STON trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCI currently has a P/E ratio of 22.27, whereas STON's P/E ratio is -6.64. In terms of profitability, SCI's ROE is +0.34%, compared to STON's ROE of +0.48%. Regarding short-term risk, SCI is more volatile compared to STON. This indicates potentially higher risk in terms of short-term price fluctuations for SCI.Check STON's competition here